We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$78.1B
AUM Growth
-$1.98B
(-2.5%)
Cap. Flow
-$7.02B
Cap. Flow
% of AUM
-8.99%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$440M |
| 2 |
C.H. Robinson
CHRW
|
+$323M |
| 3 |
Advanced Micro Devices
AMD
|
+$322M |
| 4 |
Tyler Technologies
TYL
|
+$317M |
| 5 |
Merck
MRK
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$11.9B |
| 2 |
NVIDIA
NVDA
|
+$409M |
| 3 |
Autodesk
ADSK
|
+$261M |
| 4 |
Salesforce
CRM
|
+$258M |
| 5 |
Clorox
CLX
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.82% |
| 2 | Materials | 22.17% |
| 3 | Healthcare | 8.64% |
| 4 | Industrials | 7.37% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Qfin Holdings
QFIN
$1.69B
| $643K | ﹤0.01% |
16,761
+125
| +0.8% | +$4.33K |
|
1102
Lemonade
LMND
$4.1B
| $640K | ﹤0.01% |
17,439
-615
| -3% | -$19.6K |
|
1103
Cellebrite
CLBT
$3.76B
| $639K | ﹤0.01% |
+28,988
| New | +$558K |
|
1104
DaVita
DVA
$15B
| $633K | ﹤0.01% |
4,232
-192
| -4% | -$30.1K |
|
1105
EPR Properties
EPR
$4.69B
| $631K | ﹤0.01% |
14,258
+1,321
| +10% | +$60.5K |
|
1106
Conagra Brands
CAG
$7.14B
| $628K | ﹤0.01% |
22,628
-41
| -0.2% | -$1.16K |
|
1107
NovoCure
NVCR
$1.78B
| $628K | ﹤0.01% |
21,059
-3,185
| -13% | -$67.4K |
|
1108
Cheniere Energy
CQP
$32.4B
| $626K | ﹤0.01% |
11,779
+3,336
| +40% | +$175K |
|
|
HOLX
1109
DELISTED
Hologic
HOLX
| $615K | ﹤0.01% |
8,529
-389
| -4% | -$30.4K |
|
1110
Open Text
OTEX
$6.34B
| $612K | ﹤0.01% |
21,634
+158
| +0.7% | +$4.86K |
|
1111
Viking Therapeutics
VKTX
$3.8B
| $600K | ﹤0.01% |
14,911
+5,475
| +58% | +$312K |
|
1112
Teledyne Technologies
TDY
$31.1B
| $597K | ﹤0.01% |
1,286
-116
| -8% | -$54.1K |
|
1113
Metallus
MTUS
$851M
| $595K | ﹤0.01% |
42,141
+565
| +1% | +$8.53K |
|
|
GRP.U
1114
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $585K | ﹤0.01% |
12,062
+1,126
| +10% | +$60.1K |
|
|
RYZ
1115
Ryerson Holding Corp
RYZ
$1.46B
| $585K | ﹤0.01% |
31,582
-181
| -0.6% | -$4.06K |
|
1116
Delta Air Lines
DAL
$60.2B
| $568K | ﹤0.01% |
9,392
+5,194
| +124% | +$307K |
|
1117
Broadstone Net Lease
BNL
$4.08B
| $567K | ﹤0.01% |
35,730
+3,311
| +10% | +$57.7K |
|
1118
Suzano
SUZ
$10.5B
| $553K | ﹤0.01% |
54,620
+6,202
| +13% | +$63.5K |
|
1119
National Health Investors
NHI
$3.68B
| $552K | ﹤0.01% |
7,959
+767
| +11% | +$58.3K |
|
1120
Park Hotels & Resorts
PK
$3.04B
| $547K | ﹤0.01% |
38,852
+2,895
| +8% | +$42.5K |
|
1121
Tenet Healthcare
THC
$20.1B
| $538K | ﹤0.01% |
4,262
-194
| -4% | -$28.8K |
|
1122
Acadia Realty Trust
AKR
$3.07B
| $536K | ﹤0.01% |
22,194
+4,467
| +25% | +$110K |
|
1123
ENI
E
$79B
| $532K | ﹤0.01% |
19,443
+266
| +1% | +$7.79K |
|
1124
Halozyme
HALO
$9.76B
| $531K | ﹤0.01% |
11,110
-506
| -4% | -$25.9K |
|
1125
Western Digital
WDC
$182B
| $530K | ﹤0.01% |
11,752
+5,539
| +89% | +$278K |
|
Similar funds
VanEck Associates's Q4 2024 Portfolio in Review
As of Q4 2024, VanEck Associates held 1,440 positions worth $78.1B, down 2.5% from $80.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates withdrew a net $7.02B in Q4 2024, closing 54 positions and reducing 452 holdings. Its most notable exit was Bank of New York Mellon, an estimated $9.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 41% a quarter earlier, followed by Materials and Healthcare.
Against the trend, VanEck Associates opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $251M.
- VanEck Associates's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 4,123,397 shares worth $251M.
- VanEck Associates added most to Kinross Gold in Q4 2024, an estimated $440M increase.
- VanEck Associates's biggest Q4 2024 reduction was Lam Research, cutting an estimated $11.9B.
- VanEck Associates fully exited Bank of New York Mellon in Q4 2024, selling an estimated $9.49M.
- VanEck Associates's ten largest holdings make up 29% of its $78.1B portfolio in Q4 2024.
- VanEck Associates opened 63 new positions and closed 54 in Q4 2024.
- VanEck Associates's portfolio value fell 2.5% quarter-over-quarter to $78.1B.
Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.